Clinical Trial Update: Saliva Insulin as Biomarker of Risk Factors for Metabolic Dysregulation and Caries [NA]

View source ↗

Summary

A completed clinical trial investigating saliva insulin as a biomarker of risk factors for metabolic dysregulation and dental caries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries

Snippet

Sponsor: Jodi Stookey | Conditions: Caries, Metabolomic Profile | NA | Status: COMPLETED